iBaltic LAB - Company finances
|
EUR
|
2022
From: 2022-02-28
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 24,931 | 70,551 | 86,770 | 82,902 |
| Profit before tax | 17,401 | 16,892 | 12,123 | 12,704 |
| Net profit | 16,531 | 16,037 | 11,494 | 11,904 |
| Equity | 19,031 | 32,715 | 29,259 | 37,044 |
| Liabilities | 1,185 | 10,636 | 16,497 | 12,760 |
| Non-current assets | 0 | 0 | 0 | 1,085 |
| Current assets | 20,216 | 43,351 | 45,756 | 48,719 |
| Total assets | 20,216 | 43,351 | 45,756 | 49,804 |
|
Taxes paid
|
||||
| STI taxes | - | 2,460 | 4,292 | 3,143 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +183.0% | +23.0% | -4.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 81.8% | 37.0% | 25.1% | 23.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 86.9% | 49.0% | 39.3% | 32.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 66.3% | 22.7% | 13.2% | 14.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 69.8% | 23.9% | 14.0% | 15.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.3 | 0.6 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 12,466 | 35,276 | 43,385 | 41,451 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
iBaltic LAB - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-12-18 | 2024-01-09 | 0.73 |
| 2023-11-16 | 2023-12-11 | 0.73 |
| 2023-10-17 | 2023-11-09 | 0.73 |
| 2023-09-18 | 2023-10-09 | 0.73 |
| 2023-08-17 | 2023-09-10 | 0.73 |
| 2023-07-28 | 2023-08-09 | 0.73 |
| 2023-07-24 | 2023-07-25 | 0.75 |
| 2023-05-16 | 2023-05-23 | 278.86 |
| 2022-11-21 | 2022-12-13 | 0.04 |
| 2022-11-17 | 2022-11-18 | 0.04 |
| 2022-10-28 | 2022-11-14 | 0.04 |
iBaltic LAB - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-02-02 | 2025-02-10 | 1.0 |
| 2025-01-22 | 2025-02-01 | 0.98 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
iBaltic LAB, UAB (code 306026389) is a Private Limited Liability Company operating in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated revenue of €82.9K and net profit of €11.9K, with a profit margin of 14.4%. Revenue declined by 4.5% year on year from 2024, but remained above the 2023 level of €70.6K, indicating a generally positive two-year trend. Net profit was €16.0K in 2023, €11.5K in 2024 and €11.9K in 2025, showing a dip followed by a small recovery. The balance sheet strengthened in 2025, with total assets of €49.8K, equity of €37.0K and liabilities of €12.8K. Short-term assets amounted to €48.7K, while long-term assets were €1.1K. Key indicators point to a solid capital structure, including an equity ratio of 74.4% and debt-to-equity of 0.34. Return on equity was 32.1%, return on assets 23.9%, and asset turnover 1.66x. Revenue per employee was €41.5K and profit per employee €6.0K.